Cargando…
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 (COVID-19)” pandemic. In the past two decades, the world has witnessed the emergence of two other similar CoVs, namely...
Autores principales: | Chavda, Vivek P., Bezbaruah, Rajashri, Athalye, Mansi, Parikh, Palak K., Chhipa, Abu Sufiyan, Patel, Snehal, Apostolopoulos, Vasso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025561/ https://www.ncbi.nlm.nih.gov/pubmed/35458489 http://dx.doi.org/10.3390/v14040759 |
Ejemplares similares
-
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
por: Chavda, Vivek P., et al.
Publicado: (2022) -
A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
por: Chavda, Vivek P, et al.
Publicado: (2021) -
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
por: Chavda, Vivek P., et al.
Publicado: (2023) -
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
por: Chavda, Vivek P., et al.
Publicado: (2023) -
Inhalable Vaccines: Can They Help Control Pandemics?
por: Chavda, Vivek P., et al.
Publicado: (2022)